Biocon Limited
BIOCON
Rank in Stocks
#3441
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Share Price
$3.68
Market Cap
$5.03B
Change (1 day)
-1.91%
Change (1 year)
-11.51%
Country
IN
Trade Biocon Limited (BIOCON)
Category
Healthcare
Stock price history for Biocon Limited (BIOCON)
Highest end of day price: $3.90 on 2026-10-01
Lowest end of day price: $1.16 on 2004-04-01
Lowest end of day price: $1.16 on 2004-04-01
Stock price history of Biocon Limited from 2004 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -0.41% |
| 2025 | 3.10% |
| 2024 | 43.03% |
| 2023 | -9.84% |
| 2022 | -32.34% |
| 2021 | -21.74% |
| 2020 | 51.69% |
| 2019 | -7.50% |
| 2018 | 8.33% |
| 2017 | 76.96% |
| 2016 | 90.65% |
| 2015 | 2.58% |
| 2014 | 4.05% |
| 2013 | 29.61% |
| 2012 | -4.48% |
| 2011 | -38.93% |
| 2010 | 49.26% |
| 2009 | 165.57% |
| 2008 | -69.07% |
| 2007 | 80.35% |
| 2006 | -25.48% |
| 2005 | -5.27% |
| 2004 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
